November 3, 2016 / 9:26 PM / 3 years ago

BRIEF-Cytomx therapeutics announces Q3 2016 results; provides pipeline update

Nov 3 (Reuters) - Cytomx Therapeutics Inc

* Qtrly loss per share $0.40; co expects “its existing capital resources will be sufficient to fund operations through 2018”

* Cytomx Therapeutics announces third quarter 2016 financial results and provides pipeline update Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below